Internal Medicine NewsTaking a new obesity drug and birth control pills? Be carefulOctober 19, 2023ObesityDiabetesEndocrinologyWomen's Health
Internal Medicine NewsDocs weigh in on insurance coverage for obesity medicationsOctober 18, 2023ObesityBusiness of Medicine
Internal Medicine NewsScientists find the ‘on’ switch for energy-burning brown fatOctober 18, 2023ObesityEndocrinology
Internal Medicine NewsNew ‘twincretin’ pemvidutide: Another option for obesityOctober 17, 2023Obesity
Internal Medicine NewsRoflumilast side effect benefits patients with psoriasis and overweight/obesityOctober 16, 2023DermatologyObesity
Internal Medicine NewsAre they ‘antiobesity medications’ or ‘weight-loss drugs’?October 12, 2023Obesity
Internal Medicine NewsThe new word in liver disease: The story behind NAFLD’s rebranding as MASLDOctober 5, 2023GastroenterologyObesity
Internal Medicine NewsWeight loss with semaglutide maintained for up to 3 yearsOctober 4, 2023DiabetesObesity
Internal Medicine NewsFDA gives semaglutide two drug safety–related label changesSeptember 28, 2023DiabetesGastroenterologyObesity
Internal Medicine NewsThe ‘triple-G’ agonist for obesity management: Five things to knowSeptember 25, 2023Obesity
Internal Medicine NewsTirzepatide superior to semaglutide for A1c control, weight lossSeptember 25, 2023DiabetesObesity
Internal Medicine NewsWaist-hip ratio a stronger mortality predictor than BMISeptember 21, 2023Obesity
